BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18632613)

  • 1. Thymoquinone triggers inactivation of the stress response pathway sensor CHEK1 and contributes to apoptosis in colorectal cancer cells.
    Gali-Muhtasib H; Kuester D; Mawrin C; Bajbouj K; Diestel A; Ocker M; Habold C; Foltzer-Jourdainne C; Schoenfeld P; Peters B; Diab-Assaf M; Pommrich U; Itani W; Lippert H; Roessner A; Schneider-Stock R
    Cancer Res; 2008 Jul; 68(14):5609-18. PubMed ID: 18632613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism.
    Gali-Muhtasib H; Diab-Assaf M; Boltze C; Al-Hmaira J; Hartig R; Roessner A; Schneider-Stock R
    Int J Oncol; 2004 Oct; 25(4):857-66. PubMed ID: 15375533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of p53 augments thymoquinone-induced apoptosis and caspase activation in human osteosarcoma cells.
    Roepke M; Diestel A; Bajbouj K; Walluscheck D; Schonfeld P; Roessner A; Schneider-Stock R; Gali-Muhtasib H
    Cancer Biol Ther; 2007 Feb; 6(2):160-9. PubMed ID: 17218778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53-regulated transcriptional program associated with genotoxic stress-induced apoptosis.
    Kho PS; Wang Z; Zhuang L; Li Y; Chew JL; Ng HH; Liu ET; Yu Q
    J Biol Chem; 2004 May; 279(20):21183-92. PubMed ID: 15016801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of compensatory pro-survival and anti-apoptotic modulator, IKKε, sensitizes ovarian cancer cells to CHEK1 loss through an increased level of p21.
    Kim MK; Min DJ; Wright G; Goldlust I; Annunziata CM
    Oncotarget; 2014 Dec; 5(24):12788-802. PubMed ID: 25474241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Checkpoint Kinase 1 Expression Predicts Poor Prognosis in Nigerian Breast Cancer Patients.
    Ebili HO; Iyawe VO; Adeleke KR; Salami BA; Banjo AA; Nolan C; Rakha E; Ellis I; Green A; Agboola AOJ
    Mol Diagn Ther; 2018 Feb; 22(1):79-90. PubMed ID: 29075961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA damage signaling in response to 5-fluorouracil in three colorectal cancer cell lines with different mismatch repair and TP53 status.
    Adamsen BL; Kravik KL; De Angelis PM
    Int J Oncol; 2011 Sep; 39(3):673-82. PubMed ID: 21674128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer.
    Abdel-Fatah TM; Middleton FK; Arora A; Agarwal D; Chen T; Moseley PM; Perry C; Doherty R; Chan S; Green AR; Rakha E; Ball G; Ellis IO; Curtin NJ; Madhusudan S
    Mol Oncol; 2015 Mar; 9(3):569-85. PubMed ID: 25468710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Checkpoint kinase 1 down-regulation by an inducible small interfering RNA expression system sensitized in vivo tumors to treatment with 5-fluorouracil.
    Ganzinelli M; Carrassa L; Crippa F; Tavecchio M; Broggini M; Damia G
    Clin Cancer Res; 2008 Aug; 14(16):5131-41. PubMed ID: 18698031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy.
    Wang S; El-Deiry WS
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15095-100. PubMed ID: 14645705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celecoxib induces p53-PUMA pathway for apoptosis in human colorectal cancer cells.
    Liu HF; Hsiao PW; Chao JI
    Chem Biol Interact; 2008 Oct; 176(1):48-57. PubMed ID: 18760266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemogenetic profiling identifies RAD17 as synthetically lethal with checkpoint kinase inhibition.
    Shen JP; Srivas R; Gross A; Li J; Jaehnig EJ; Sun SM; Bojorquez-Gomez A; Licon K; Sivaganesh V; Xu JL; Klepper K; Yeerna H; Pekin D; Qiu CP; van Attikum H; Sobol RW; Ideker T
    Oncotarget; 2015 Nov; 6(34):35755-69. PubMed ID: 26437225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 90-kDa heat shock protein inhibition abrogates the topoisomerase I poison-induced G2/M checkpoint in p53-null tumor cells by depleting Chk1 and Wee1.
    Tse AN; Sheikh TN; Alan H; Chou TC; Schwartz GK
    Mol Pharmacol; 2009 Jan; 75(1):124-33. PubMed ID: 18820127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of p53 status and STAT1 on chemotherapy-induced, Fas-mediated apoptosis in colorectal cancer.
    McDermott U; Longley DB; Galligan L; Allen W; Wilson T; Johnston PG
    Cancer Res; 2005 Oct; 65(19):8951-60. PubMed ID: 16204068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymoquinone from Nigella sativa Seeds Promotes the Antitumor Activity of Noncytotoxic Doses of Topotecan in Human Colorectal Cancer Cells in Vitro.
    Khalife R; Hodroj MH; Fakhoury R; Rizk S
    Planta Med; 2016 Mar; 82(4):312-21. PubMed ID: 26848703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulated expression of cryptochrome genes in human colorectal cancer.
    Mazzoccoli G; Colangelo T; Panza A; Rubino R; De Cata A; Tiberio C; Valvano MR; Pazienza V; Merla G; Augello B; Trombetta D; Storlazzi CT; Macchia G; Gentile A; Tavano F; Vinciguerra M; Bisceglia G; Rosato V; Colantuoni V; Sabatino L; Piepoli A
    Mol Cancer; 2016 Jan; 15():6. PubMed ID: 26768731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymoquinone induces telomere shortening, DNA damage and apoptosis in human glioblastoma cells.
    Gurung RL; Lim SN; Khaw AK; Soon JF; Shenoy K; Mohamed Ali S; Jayapal M; Sethu S; Baskar R; Hande MP
    PLoS One; 2010 Aug; 5(8):e12124. PubMed ID: 20711342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-195 suppresses non-small cell lung cancer by targeting CHEK1.
    Liu B; Qu J; Xu F; Guo Y; Wang Y; Yu H; Qian B
    Oncotarget; 2015 Apr; 6(11):9445-56. PubMed ID: 25840419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53/microRNA-374b/AKT1 regulates colorectal cancer cell apoptosis in response to DNA damage.
    Gong H; Cao Y; Han G; Zhang Y; You Q; Wang Y; Pan Y
    Int J Oncol; 2017 May; 50(5):1785-1791. PubMed ID: 28339062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinatorial effects of thymoquinone on the anti-cancer activity of doxorubicin.
    Effenberger-Neidnicht K; Schobert R
    Cancer Chemother Pharmacol; 2011 Apr; 67(4):867-74. PubMed ID: 20582416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.